Home538965 • BOM
add
Concord Drugs Ltd
Previous close
₹82.96
Day range
₹80.20 - ₹86.90
Year range
₹26.10 - ₹92.52
Market cap
840.00M INR
Avg Volume
10.12K
P/E ratio
145.36
Dividend yield
-
Primary exchange
BOM
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 102.76M | -16.86% |
Operating expense | 17.98M | 6.78% |
Net income | 1.92M | 343.32% |
Net profit margin | 1.87 | 434.29% |
Earnings per share | — | — |
EBITDA | 11.13M | 28.91% |
Effective tax rate | 29.08% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.65M | 582.43% |
Total assets | 686.13M | -6.35% |
Total liabilities | 341.94M | -13.17% |
Total equity | 344.19M | — |
Shares outstanding | 10.13M | — |
Price to book | 2.44 | — |
Return on assets | — | — |
Return on capital | 3.55% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 1.92M | 343.32% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1995
Website
Employees
250
